<DOC>
	<DOCNO>NCT00705822</DOCNO>
	<brief_summary>To compare efficacy strategy ( reference treatment : Docetaxel+Prednisone experimental treatment : Docetaxel+Estramustine+Hydrocortisone ) mean PSA value . To determine time treatment failure strategy To determine overall specific cause survival To evaluate safety profile To analyze Quality Life</brief_summary>
	<brief_title>Combination Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone Patients With Advanced Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Estramustine</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Histological cytological confirmation prostate adenocarcinoma Advanced prostate carcinoma . Previous treatment hormone Levels testosterone &lt; 50 ng/dL Good hematological , liver kidney function Previous treatment surgery radiotherapy , least 4 week since end treatment allow ( patient recover side effect . Previous chemotherapy ( estramustine include ) . Second line hormonotherapy ( oestrogen , gestagens , ketoconazole , ... include ) Previous treatment radiotherapy ( isotope ) previous radiotherapy &gt; 25 % marrow Any malignant process free disease interval 5 year , exception do nonmelanoma skin cancer . Concomitant serious disease Concomitant treatment neoplassic therapy ( exception do LHRH agonist and/or biphosphonates ) . Contraindication treatment estramustine . Previous history pulmonary embolism , thromboembolic disease , previous treatment anticoagulant ( except aspirin ) , active thrombophlebitis hypercoagulation . Previous history pulmonary spillage ascitis . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>